1. You Missed One
    toeser toeser United States says:
    October 4, 2010 at 4:34 PM

    Keep your eye on Oncolytics Biotech, Inc. (ONCY).  By 2019, they will likely have a chunk of this market with their live virus - reolysin - treatment.  They are likely getting very close to a partnership and accelerated testing for various cancers.  Non-small-cell lung cancer is on their radar screen, and they are currently in phase III for head and neck cancers.

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback